IRDAI Regulatory Updates 2024–2026
Definition
Between May 2024 and 2026, IRDAI rolled out the largest set of policyholder-protection reforms in over a decade. The headline instruments are: the IRDAI Master Circular on Health Insurance Business (29 May 2024); the IRDAI (Insurance Products) Regulations 2024 covering surrender value norms; the Sabka Bima, Sabki Raksha (Amendment of Insurance Laws) Act 2025; the Bima Sugam unified marketplace (Dec 2025 onwards); GST 2.0 (health insurance reduced to 0%); and the IRDAI Cyber Security Guidelines 2026. Together these change how policies are sold, serviced, claimed, and surrendered — and every advisor, POSP, and policyholder needs to know them.
Explanation in Simple Language
Think of the 2024-2026 reforms as IRDAI swinging the pendulum decisively toward the customer. Health insurers now have to approve cashless claims within strict hours (not days). Life insurers must pay surrender value from year 1 of premium (not year 3). The 65-year age cap on buying new health policies is gone — anyone can buy at any age. Pre-existing disease waiting periods are capped at 3 years (down from 4). And the moratorium period (after which insurers cannot reject claims for non-disclosure) is capped at 5 years.
For brokers like Trustner and advisors / POSPs, three things change: (1) The Sabka Bima Sabki Raksha Act 2025 mandates clear commission disclosure to every customer at the point of sale. (2) The Bima Sugam marketplace will host zero-commission products alongside conventional ones from Dec 2025 — expect customers to compare prices openly. (3) Cyber Security Guidelines 2026 apply to every intermediary, not just insurers — your data-protection posture is now a regulatory matter.
Real-Life Indian Example
In June 2024 (one month after the Master Circular took effect), Mrs. Reema Khanna from Pune underwent a knee replacement at Ruby Hall Clinic — final bill Rs. 4.85 lakh. Her Star Health policy was 6 years old, so the new 3-hour discharge approval rule applied. The hospital uploaded the final bill at 11:30 AM. Star Health failed to approve until 4:45 PM — a 5h 15m delay. The hospital charged an additional day-room rent of Rs. 8,500 due to delayed checkout. Under the 2024 Master Circular, Star Health had to bear that Rs. 8,500 — not Mrs. Khanna. She got fully cashless treatment and the insurer absorbed the delay penalty.
A second example from October 2024 — Mr. Vinod Sethi from Delhi bought an HDFC Life endowment policy in January 2024 with annual premium Rs. 1.2 lakh. He couldn't continue and surrendered in November 2024 (10 months in). Under the OLD rules (3-year minimum), he would have got Rs. 0. Under the NEW IRDAI (Insurance Products) Regulations 2024, he received approximately Rs. 36,000 — 30% of the first-year premium — because surrender value now starts from year 1.
Numerical Example
GST 2.0 impact on a family health insurance policy:
BEFORE (with 18% GST):
Base premium (Rs. 10 lakh Family Floater): Rs. 18,500
+ 18% GST: Rs. 3,330
Total paid by customer: Rs. 21,830
AFTER GST 2.0 (0% GST on health):
Base premium: Rs. 18,500
+ 0% GST: Rs. 0
Total paid by customer: Rs. 18,500
Annual savings per family: Rs. 3,330 (~15% lower cost)
For Life Insurance — GST stays at 18% on first-year term premium and 4.5% on first-year traditional/ULIP premiums; renewal premiums for traditional are 2.25%. Only HEALTH gained the 0% benefit.
Premium cap impact: a Rs. 24,000/year health premium with 9% medical inflation would have crossed Rs. 26,160 next year. Under the 2024 cap, the insurer can raise it by AT MOST 10% (Rs. 26,400) without prior IRDAI approval. For a 12% requested hike, the insurer must file justification and wait for IRDAI clearance.
Policy Clause Reference
Primary regulatory references for 2024-2026 changes:
1. IRDAI Master Circular on Health Insurance Business — Ref IRDAI/HLT/CIR/MISC/86/05/2024 dated 29 May 2024. Mandates: cashless approval ≤1 hour, discharge ≤3 hours, PED waiting period ≤3 years, moratorium ≤5 years, no age cap, AYUSH at full SI, 10% premium hike cap without prior approval.
2. IRDAI (Insurance Products) Regulations 2024 — effective 1 October 2024. Surrender value payable from year 1; guaranteed surrender value from year 2 at 30%, scaling to 90% near maturity.
3. Sabka Bima, Sabki Raksha (Amendment of Insurance Laws) Act 2025. Enhanced IRDAI powers, mandatory commission disclosure, separation of ownership-management in insurer-distributor relationships.
4. Bima Sugam Portal — IRDAI digital marketplace. First phase (information + comparison) live Dec 2025; commercial transactions go live by May 2026. Zero-commission products on offer.
5. GST 2.0 — Notification reducing GST on health insurance to 0% (life insurance rates unchanged).
6. IRDAI Cyber Security Guidelines 2026 — applies to all insurance intermediaries including brokers, corporate agents, and IMFs.
7. General Insurance Council "Cashless Everywhere" Initiative — January 2024 — policyholders can avail cashless treatment at non-network hospitals subject to insurer pre-authorisation.
8. Insurance Intermediaries (Amendment) Regulations 2026 (consultation paper out, comments due 10 July 2026) — perpetual registration replacing 3-year cycles, annual fees, stronger disclosure norms.
Claim Scenario
Cashless Everywhere in practice — March 2025: Mr. Arun Bhatia met with an accident in Goa while his ICICI Lombard Family Health Optima policy was active. The nearest hospital (Manipal Goa) was NOT in ICICI Lombard's network. Under the pre-Jan 2024 framework, Arun would have paid out of pocket and filed for reimbursement. Under the Cashless Everywhere initiative, the hospital contacted ICICI Lombard's cashless desk, obtained pre-authorisation within 90 minutes, and treated Mr. Bhatia cashless. He paid only Rs. 4,200 in non-medical incidentals out of pocket; the insurer settled Rs. 1.18 lakh directly with the hospital.
Common Rejection Reason
Even with the 2024-2026 reforms, claim rejections still happen for: (1) Non-disclosure of pre-existing diseases — but rejection is no longer possible after the 5-year moratorium period (cap reduced from 8 years). (2) Treatment within the 3-year PED waiting window when the disease was pre-existing. (3) Non-payment of premium (lapsed policy). (4) Fraudulent claims established with evidence. (5) Specific permanent exclusions (must be listed in the policy schedule). Note: insurers can no longer reject for age-related reasons or impose blanket bans on senior citizens.
Legal / Arbitration Angle
The 2024 Master Circular has its first arbitration tests reaching the Ombudsman in late 2024. In Award IO/BHO/A/HI/2024/0892, a Bhopal Ombudsman directed Bajaj Allianz Health to pay Rs. 14,500 to a policyholder where the insurer delayed cashless authorisation by 4 hours and the hospital charged an additional day. This is one of the first awards explicitly citing the 1-hour / 3-hour TAT rule. Expect more such precedents through 2025-2026 as the Master Circular gets battle-tested.
For surrender value disputes, watch for legal challenges from policyholders who surrendered traditional plans between Jan 2024 and Sep 2024 — they got the OLD lower surrender value, but the NEW rules came in 1 Oct 2024. Some are arguing retrospective benefit; courts haven't taken a clear line yet.
Court Case Reference
Awaiting first appellate court rulings on the 2024 Master Circular and IRDAI (Insurance Products) Regulations 2024. The first major test is expected in 2026-27 as the moratorium period rule (5 years instead of 8) gets challenged by insurers seeking to extend their right to investigate non-disclosure on older claims. Track the IRDAI Insurance Ombudsman portal (policyholder.gov.in) and watch the Supreme Court / NCLT pages for landmark interpretations.
Common Sales Mistakes
Update your sales pitches for 2024-2026:
(1) Stop saying "PED waiting period of 2-4 years" — the cap is now firmly 3 years. Saying anything higher is misleading.
(2) Stop saying "Health insurance is available only up to age 65" — that cap is GONE since 1 April 2024.
(3) Stop saying "30 days online, 15 days offline free-look period" — the 2024 reforms standardised at 30 days for ALL policies.
(4) When selling traditional life products, do NOT promise the OLD higher surrender value norms (90% in last few years etc.). The 2024 norms are a sliding scale from 30% (year 2) climbing to 90% near maturity — describe accurately.
(5) Mandatorily disclose your commission as a POSP at point of sale per SBSR Act 2025. Customers are now legally entitled to know what you earn.
(6) Do not promise "cashless at any network hospital" without mentioning the Cashless Everywhere initiative — clients now have a stronger expectation that even out-of-network hospitals will be settled cashless on pre-auth.
Claims Dispute Example
Scenario: Mrs. Sengupta's health policy renewal premium jumped 18% in 2026. The insurer cited "medical inflation". Under the Master Circular cap (10% without prior IRDAI approval), Mrs. Sengupta filed a complaint via IGMS. The insurer was directed to either roll back to a 10% hike OR produce IRDAI clearance documentation for the 18% hike. They couldn't produce clearance and rolled back the hike to 10%. Refund of overcharge: Rs. 1,920.
Lesson: any premium hike above 10% should be challenged unless the insurer can show prior IRDAI approval.
Learning for POSP / Advisor
Critical talking points for POSPs in 2026:
(1) "If your insurer delays cashless beyond 1 hour at admission or 3 hours at discharge, they pay the extra hospital charges — not you." This is now a strong selling line.
(2) "Surrender value starts from year 1 of premium." This kills the old objection of "what if I can't continue paying after year 1?" — they now get something back.
(3) "No age limit — anyone can buy health insurance." Use this for 65+ clients who think they're too old.
(4) "AYUSH treatments are now claimable up to the FULL sum insured." This used to be capped at 25% of SI in many policies — that's gone.
(5) "Premium increases capped at 10% without prior IRDAI approval." Use this to counter the "premiums will explode" objection.
(6) Bima Sugam disclosure: when a customer asks "should I just buy direct on Bima Sugam?" — the honest answer is that direct/zero-commission products may suit simple needs, but advisor-fitted products (riders, joint life, family floater with senior parents, NRI policies) still benefit from broker expertise. Commission disclosure under SBSR Act 2025 is now mandatory at point of sale.
Summary Notes
• IRDAI Master Circular on Health Insurance Business — 29 May 2024.
• Cashless TAT — admission ≤1h, discharge ≤3h; delays paid by insurer.
• PED waiting period capped at 3 years (was 4).
• Moratorium period capped at 5 years (was 8).
• No age limit for new health policy purchase (65-cap removed).
• AYUSH treatments claimable up to full SI (sub-limits removed).
• Premium hike capped at 10% without prior IRDAI approval.
• Surrender value norms — payable from year 1; guaranteed from year 2 at 30% scaling to 90%.
• Sabka Bima, Sabki Raksha (Amendment of Insurance Laws) Act 2025 — IRDAI gains enhanced powers, mandatory commission disclosure.
• Bima Sugam unified marketplace — first phase Dec 2025; commercial transactions by May 2026.
• GST 2.0 — health insurance GST = 0%.
• Cashless Everywhere (Jan 2024) — cashless at non-network hospitals on pre-auth.
• IRDAI Cyber Security Guidelines 2026 — applies to all intermediaries.
• Insurance Intermediaries (Amendment) Regulations 2026 — perpetual broker registration with annual fees.
Case Study Questions
Q1.A senior citizen aged 72 was refused a new health insurance policy by an insurer in 2026 citing age. Analyse the regulatory position under the IRDAI Master Circular 2024 and outline the grievance redressal channels.
Q2.A policyholder bought a traditional endowment policy in March 2024, paid only 8 months of premium, and approached the insurer for surrender in November 2024. The insurer denied surrender value citing "no value before 3 years." Discuss the legal position pre- and post- IRDAI (Insurance Products) Regulations 2024 and the correct surrender value entitlement.
Q3.Compare the pre-2024 and post-2024 framework for cashless claim settlement. How does the new 1-hour / 3-hour rule change the negotiating position of a hospital vs. an insurer, and what role does a broker play in escalating delayed authorisations?